Dyadic International, Inc. (DYAI)
0.503
-0.01
(-2.12%)
USD |
NASDAQ |
Sep 10, 11:45
Dyadic International Shareholders Equity (Quarterly) : -2.387M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -2.387M |
| March 31, 2026 | -0.4077M |
| December 31, 2025 | 1.232M |
| September 30, 2025 | 2.607M |
| June 30, 2025 | -0.5297M |
| March 31, 2025 | 0.9236M |
| December 31, 2024 | 2.470M |
| September 30, 2024 | 3.412M |
| June 30, 2024 | 3.168M |
| March 31, 2024 | 4.516M |
| December 31, 2023 | 5.879M |
| September 30, 2023 | 7.652M |
| June 30, 2023 | 8.986M |
| March 31, 2023 | 10.80M |
| December 31, 2022 | 11.09M |
| September 30, 2022 | 12.61M |
| June 30, 2022 | 13.56M |
| March 31, 2022 | 16.39M |
| December 31, 2021 | 18.39M |
| September 30, 2021 | 21.90M |
| June 30, 2021 | 23.16M |
| March 31, 2021 | 25.69M |
| December 31, 2020 | 28.45M |
| September 30, 2020 | 29.99M |
| June 30, 2020 | 32.09M |
| Date | Value |
|---|---|
| March 31, 2020 | 34.25M |
| December 31, 2019 | 35.86M |
| September 30, 2019 | 37.24M |
| June 30, 2019 | 38.62M |
| March 31, 2019 | 40.59M |
| December 31, 2018 | 42.45M |
| September 30, 2018 | 42.91M |
| June 30, 2018 | 46.30M |
| March 31, 2018 | 47.83M |
| December 31, 2017 | 49.98M |
| September 30, 2017 | 51.79M |
| June 30, 2017 | 53.23M |
| March 31, 2017 | 54.44M |
| December 31, 2016 | 57.69M |
| September 30, 2016 | 63.25M |
| June 30, 2016 | 68.03M |
| March 31, 2016 | 69.21M |
| December 31, 2015 | 73.84M |
| September 30, 2015 | -0.5896M |
| June 30, 2015 | -2.664M |
| March 31, 2015 | -2.452M |
| December 31, 2014 | -2.133M |
| September 30, 2014 | -0.7603M |
| June 30, 2014 | -0.0985M |
| March 31, 2014 | 1.358M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Agenus, Inc. | -199.08M |
| Amgen, Inc. | 11.69B |
| Anika Therapeutics, Inc. | 137.28M |
| BioCryst Pharmaceuticals, Inc. | -454.29M |
| Imunon, Inc. | 4.189M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 6.536M |
| Total Liabilities (Quarterly) | 8.924M |
| Debt to Equity Ratio | -2.114 |
| Current Ratio | 1.65 |
| Net Debt Paydown Yield | 0.01% |